v3.26.1
Events After the Reporting Date (Details) - USD ($)
$ / shares in Units, $ in Thousands
Apr. 01, 2026
Mar. 10, 2026
Jan. 13, 2026
Feb. 12, 2026
Jan. 26, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 28, 2023
Events After the Reporting Date [Line Items]                  
Percentage of lowest weighted average price 88.00%                
Trading days 20 years                
Shares issued           365,444 57,293 3,739  
Ordinary Shares [Member]                  
Events After the Reporting Date [Line Items]                  
Shares issued           192     5,291
Subsequent Events [Member]                  
Events After the Reporting Date [Line Items]                  
Percentage of share capital         113043.00%        
Exercise price per share     $ 1   $ 0.009        
Aggregate of ordinary shares     766,170            
Gross proceeds     $ 766,170            
Aggregate principal amount       $ 10,000          
Principal amount     2,000            
Purchase price     $ 1,800            
Trading days   20 years              
Aggregate investment   $ 9,460              
Earn out payments   2,500              
Subsequent Events [Member] | Bottom of range [member]                  
Events After the Reporting Date [Line Items]                  
Earn out payments   500              
Subsequent Events [Member] | Top of range [member]                  
Events After the Reporting Date [Line Items]                  
Earn out payments   $ 1,500              
Forecast [Member]                  
Events After the Reporting Date [Line Items]                  
Principal amount $ 1,800                
Percentage of purchase price 90.00%                
Percentage of amount of ordinary shares 150.00%                
Warrant coverage 100.00%                
Forecast [Member] | Initial Warrant [Member]                  
Events After the Reporting Date [Line Items]                  
Shares issued 405,728                
Exercise price $ 4.9293                
Warrant exercisable term 3 years                
NeuroThera [Member] | Subsequent Events [Member]                  
Events After the Reporting Date [Line Items]                  
Shares issued   56,600,000              
Controlling interest   75.00%              
Fundraising proceeds percentage   7.00%              
Proceeds from fundraising   $ 1,000              
CliniQuantum Ltd.[Member] | Subsequent Events [Member]                  
Events After the Reporting Date [Line Items]                  
Percentage of shares issued and outstanding   54.01%              
CliniQuantum Ltd.[Member] | Subsequent Events [Member] | Ordinary Shares [Member]                  
Events After the Reporting Date [Line Items]                  
Percentage of shares issued and outstanding   54.01%              
Shares acquired   56,375